Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$48,729,246
+$12,202,420 QoQ
Shares Held
40,627
+2.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#554
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DAVENPORT & Co LLC holds $494,810,441 across 13 Drug Manufacturers - General names. LLY ranks #3 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
862,394 | $219,022,204 | |
| 2 | SNY |
Sanofi
|
2,001,451 | $85,381,899 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
40,627 | $48,729,246 | |
| 4 | ABBV |
AbbVie Inc.
|
191,426 | $48,170,438 | |
| 5 | MRK |
Merck & Co., Inc.
|
271,897 | $34,938,764 | |
| 6 | AMGN |
Amgen Inc
|
57,790 | $20,926,914 | |
| 7 | PFE |
Pfizer Inc
|
446,366 | $10,748,493 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
120,870 | $6,964,529 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,729,246 | 40,627 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $36,526,826 | 39,713 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $40,720,703 | 37,891 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $26,047,294 | 34,138 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $24,990,172 | 32,058 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $27,479,677 | 33,272 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $25,638,892 | 33,211 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $28,586,625 | 32,267 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $28,509,510 | 31,489 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $24,371,152 | 31,327 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $18,091,505 | 31,036 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $16,920,669 | 31,502 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $15,483,374 | 33,015 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $11,799,567 | 34,359 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $12,248,323 | 33,480 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $10,582,275 | 32,727 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $10,207,408 | 31,482 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $9,045,282 | 31,586 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $7,860,392 | 28,457 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,577,993 | 28,470 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $6,544,762 | 28,515 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $5,063,569 | 27,104 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $4,209,181 | 24,930 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $3,820,544 | 25,811 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $4,262,933 | 25,965 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $3,626,556 | 26,143 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||